MIAProfessor Georgina Long — no licensed photograph is available, so the clinician plate is shown instead.

Clinician

Professor Georgina Long

Medical Director; Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia (MIA) / The University of Sydney / Royal North Shore Hospital

Press citations

2

Topic

1

Cancer

Last quoted

Aug 2026

Professor Georgina Long: key facts

Kind of voice
Clinician
Role
Medical Director; Chair of Melanoma Medical Oncology and Translational Research
Quoted on
Cancer
Tracked press citations
2
Most recently quoted
27 Aug 2026

Who Professor Georgina Long is

Professor Georgina Long AO is Medical Director of Melanoma Institute Australia (MIA) and Chair of Melanoma Medical Oncology and Translational Research at MIA, Royal North Shore Hospital, and the University of Sydney. She is a medical oncologist and clinical trialist specialising in melanoma, leading an extensive clinical trials team focused on immuno-oncology and targeted therapies, including Phase I–III trials in patients with active brain metastases. She completed a PhD in Chemistry and a Fulbright Postdoctoral Fellowship at the Scripps Research Institute before returning to Australia to qualify in medicine, becoming a Fellow of the Australasian College of Physicians in medical oncology in 2008. She was jointly named 2024 Australian of the Year with colleague Professor Richard Scolyer AO, recognised for their immunotherapy approach that has made advanced melanoma a curable disease for many patients. She is a past president of the Society for Melanoma Research (2018–2020) and is known for publicly advocating against tanning culture and for expanded access to cancer clinical trials.

“Long wanted to try everything to save her friend and Scolyer was willing to "give it a crack", knowing that their findings could make a significant difference to the lives of future brain cancer patients.”

References for this biography

  1. 1.Professor Georgina Long AO | Melanoma Institute Australia — Current role title, organisation, academic affiliations, research focus, clinical trials leadership, and career background
  2. 2.Professor Georgina Long AO and Professor Richard Scolyer AO | Australian of the Year — 2024 Australian of the Year joint award; advocacy role as media commentators on melanoma prevention
  3. 3.2018 NSW Premier's Awards for Outstanding Cancer Research — Outstanding Cancer Researcher of the Year 2018 award
  4. 4.Prof Georgina Long AO | Medical Oncologist | Mater Hospital, North Sydney — Past presidency of Society for Melanoma Research; ASCO/ESMO committee roles; 200+ conference presentations
  5. 5.Contact Us | Melanoma Institute Australia — Organisation head-office address (The Poche Centre, 40 Rocklands Road, Wollstonecraft NSW 2065) and press contact email

Notable achievements

  • Jointly named 2024 Australian of the Year (with Professor Richard Scolyer AO) for pioneering melanoma immunotherapy research that has made advanced melanoma curable for many patients. Source ↗
  • Named NSW Premier's Outstanding Cancer Researcher of the Year 2018 by Cancer Institute NSW. Source ↗
  • First woman and first Australian to be named president of the US-based Society for Melanoma Research. Source ↗
  • Has presented her work at international conferences and meetings on more than 200 occasions. Source ↗

What Professor Georgina Long has said

Where Professor Georgina Long has been quoted

  1. Richard Scolyer, acclaimed melanoma researcher who tried experimental treatment on his own brain cancer – obituarytheguardian.com · 27 Aug 2026
  2. Moderna’s cancer shot: exciting for investors, inconclusive for patientsft.com · 27 Aug 2026

Related media coverage

Recent UK press coverage of their topics — not necessarily citing them directly.

Contact & links

Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.

Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.